Jennison Associates
GNMK

Jennison Associates’s GenMark Diagnostics, Inc GNMK Stock Holding History

Jennison Associates’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-105,960
Closed -$676K – 719
2018
Q2 		$676K Sell
105,960
-86,248
-45% -$570K ﹤0.01% 592
2018
Q1 		$1.05M Sell
192,208
-1,523,556
-89% -$7.57M ﹤0.01% 560
2017
Q4 		$7.16M Sell
1,715,764
-1,851,237
-52% -$11.1M 0.01% 481
2017
Q3 		$34.4M Buy
3,567,001
+25,254
+0.7% +$262K 0.04% 323
2017
Q2 		$41.9M Buy
3,541,747
+443,005
+14% +$5.66M 0.04% 291
2017
Q1 		$39.7M Sell
3,098,742
-123,974
-4% -$1.49M 0.04% 310
2016
Q4 		$39.4M Buy
3,222,716
+342,213
+12% +$4.06M 0.04% 306
2016
Q3 		$34M Sell
2,880,503
-173,237
-6% -$1.67M 0.04% 335
2016
Q2 		$26.6M Sell
3,053,740
-170,854
-5% -$1.17M 0.03% 370
2016
Q1 		$17M Buy
3,224,594
+80,160
+3% +$446K 0.02% 423
2015
Q4 		$24.4M Buy
3,144,434
+214,822
+7% +$1.65M 0.02% 395
2015
Q3 		$23.1M Sell
2,929,612
-80,213
-3% -$742K 0.02% 412
2015
Q2 		$27.3M Sell
3,009,825
-669,492
-18% -$6.75M 0.03% 426
2015
Q1 		$47.8M Sell
3,679,317
-19,731
-0.5% -$258K 0.04% 333
2014
Q4 		$50.3M Sell
3,699,048
-62,085
-2% -$694K 0.05% 328
2014
Q3 		$33.7M Buy
3,761,133
+86,581
+2% +$932K 0.03% 386
2014
Q2 		$49.7M Sell
3,674,552
-410,013
-10% -$4.28M 0.05% 333
2014
Q1 		$40.6M Sell
4,084,565
-24,111
-0.6% -$300K 0.04% 356
2013
Q4 		$54.7M Sell
4,108,676
-112,946
-3% -$1.37M 0.05% 289
2013
Q3 		$51.3M Buy
4,221,622
+540,899
+15% +$5.8M 0.05% 297
2013
Q2 		$38.1M Buy
+3,680,723
New +$50.8M 0.04% 330

Other funds holding GNMK

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Jennison Associates's GNMK Position: Q3 2018 in Review

Jennison Associates sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2018, closing a stake of 105,960 shares — an estimated $676K sold.

Jennison Associates first reported a position in GNMK in Q2 2013 and held it in 21 quarters. The position peaked at $54.7M in Q4 2013. 106 funds tracked by Wall St. Rank hold GNMK as of Q3 2018.

  • Jennison Associates reported no remaining GenMark Diagnostics, Inc position as of Q3 2018 after selling out during the quarter.
  • Jennison Associates sold 105,960 GenMark Diagnostics, Inc shares in Q3 2018, an estimated $676K.
  • Jennison Associates first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 21 quarters.
  • Jennison Associates's GenMark Diagnostics, Inc position peaked at $54.7M in Q4 2013.
  • 106 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2018.

Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.